| scholarly article | Q13442814 |
| P2093 | author name string | Rita Nahta | |
| Lily Yang | |||
| Robert C Castellino | |||
| Siobhan M Eze | |||
| Bridgette F Peake | |||
| P2860 | cites work | MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily | Q24317134 |
| Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway | Q24620497 | ||
| GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective | Q26798142 | ||
| Recent discoveries concerning the tumor - mesenchymal stem cell interactions | Q28074616 | ||
| Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells | Q28275069 | ||
| Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum | Q30452357 | ||
| An autocrine/paracrine circuit of growth differentiation factor (GDF) 15 has a role for maintenance of breast cancer stem-like cells | Q33648678 | ||
| Screening therapeutic EMT blocking agents in a three-dimensional microenvironment | Q33689694 | ||
| Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells | Q33698448 | ||
| Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer | Q34099900 | ||
| P38 MAPK contributes to resistance and invasiveness of HER2- overexpressing breast cancer | Q34675545 | ||
| Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1. | Q34946846 | ||
| Resistance to HER2-targeted therapies: a potential role for FOXM1. | Q34955355 | ||
| Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion | Q35087191 | ||
| Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells | Q35316842 | ||
| FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells | Q35741551 | ||
| The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer | Q36592451 | ||
| GDF15 promotes EMT and metastasis in colorectal cancer | Q36729546 | ||
| GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway | Q37702121 | ||
| The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. | Q38605925 | ||
| GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates | Q38605928 | ||
| A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics. | Q38720963 | ||
| KCNN4 channels participate in the EMT induced by PRL-3 in colorectal cancer | Q39168782 | ||
| EMT and CSC-like properties mediated by the IKKβ/IκBα/RelA signal pathway via the transcriptional regulator, Snail, are involved in the arsenite-induced neoplastic transformation of human keratinocytes | Q39258711 | ||
| GDF-15 contributes to proliferation and immune escape of malignant gliomas | Q39695192 | ||
| Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells | Q39733775 | ||
| The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells | Q42473555 | ||
| Differentiation plasticity regulated by TGF-beta family proteins in development and disease | Q46933819 | ||
| GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand | Q47897710 | ||
| GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. | Q54623768 | ||
| MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma | Q73653083 | ||
| Increased expression of the TGF-b superfamily cytokine MIC-1/GDF15 protects ApoE(-/-) mice from the development of atherosclerosis | Q83563327 | ||
| Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer | Q84472567 | ||
| P433 | issue | 55 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 94393-94406 | |
| P577 | publication date | 2017-10-10 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling | |
| P478 | volume | 8 |
| Q55495948 | EZH2-Mediated Epigenetic Suppression of GDF15 Predicts a Poor Prognosis and Regulates Cell Proliferation in Non-Small-Cell Lung Cancer. |
| Q92036930 | Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts |
| Q92237192 | IGF1R facilitates epithelial-mesenchymal transition and cancer stem cell properties in neuroblastoma via the STAT3/AKT axis |
| Q60920838 | Inhibition of Breast Cancer Cell Invasion by Ras Suppressor-1 (RSU-1) Silencing Is Reversed by Growth Differentiation Factor-15 (GDF-15) |
| Q92838091 | Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers |
| Q60620984 | Solid Stress Facilitates Fibroblasts Activation to Promote Pancreatic Cancer Cell Migration |
| Q54977309 | Targeting Forkhead Box M1 Transcription Factor in Breast Cancer. |
| Q92156666 | Visfatin Mediates Malignant Behaviors through Adipose-Derived Stem Cells Intermediary in Breast Cancer |
| Q58718106 | hsa_circ_0061140 Knockdown Reverses FOXM1-Mediated Cell Growth and Metastasis in Ovarian Cancer through miR-370 Sponge Activity |
Search more.